Ulf Jonsson has been hired as Chief Executive Officer of Cellectricon. Jonsson will succeed co-founder Jakob Lindberg after his planned resignation.
Ulf Jonsson has a doctorate in applied physics and previously served as CEO at Biacore. He has also worked for Pharmacia Biotechnology/Amersham Bioscience where he served as Marketing Manager for Molecular Biological Systems. Ulf Jonsson has a record spanning more than 20 years in the biotechnology industry.
Ulf Jonsson said, “I’ve followed Cellectricon’s development with great interest, and I am privileged to become the new Chief Executive Officer. I’m especially impressed by the Dynaflow technology that offers proven productivity increase together with enhanced data quality and information content vis-a-vis all other ion-channel assays. I’m looking forward to expanding the Dynaflow product range and develop the remarkable potential of Cellectricon’s extensive IP portfolio with novel cell-based technologies”.
Cellectricon’s Chairman Axel Broms added, “I am very excited that Ulf Jonsson has agreed to join Cellectricon when we are rolling out Dynaflow on a global basis. Ulf has the skill and track record to take Cellectricon to its next phase – from successful start-up company to key life-science industry player.”